To more directly validate that primary human peripheral monocytes were the principal target cells supporting the enhancement of ZIKV infection in the presence of DENV immune serum, we positively enriched CD14+ monocytes from PBMCs via magnetic microbeads before performing virus inoculation. This evidence concerns the gene CD14 and Zika virus infectious disease.